MYC expression and distribution in normal mature lymphoid cells.

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• The distribution of the MYC proto-oncogene product in lymphoid tissue remains poorly understood due to technical challenges.
• Previous studies were limited by antibody sensitivity, specificity, and the low abundance and short half-life of MYC.
• A clear understanding of MYC expression is crucial for comprehending B cell biology and oncogenesis.

Purpose of the Study:

• To validate antibodies for MYC detection in lymphoid tissues.
• To define the expression and distribution of MYC in mature normal lymphoid cells using multiparametric immunophenotyping.
• To clarify MYC's role in different B cell subsets and its cell cycle association.

Main Methods:

• Validation of two antibodies for MYC detection using flow cytometry and immunohistochemistry.
• Analysis of normal human tonsil tissue.
• Multiparametric immunophenotyping to identify MYC-expressing cell populations.

Main Results:

• MYC is predominantly expressed in B cells, including activated, cycling blasts (CD30+, IRF4+, AID±) and resting B lymphocytes (follicular mantle, memory B cells, FcRH4/IRTA1+ B cells).
• MYC is also found in germinal center founder cells and light zone germinal center cells.
• MYC expression occurs across all cell cycle phases in activated/mature B cells, but is rare in other lymphoid types.

Conclusions:

• Validated antibodies enable precise mapping of MYC expression in normal lymphoid tissue.
• MYC expression is a feature of diverse mature and activated B cell subsets.
• The observed MYC distribution partially differs from previous ex vivo and extractive experimental predictions.